Login / Signup

A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma.

Max J GordonSigrid DuboisBonita BryantSamuel NgKevin ConlonMilos D MiljkovicThomas WaldmannMark Roschewski
Published in: Leukemia & lymphoma (2024)
Keyphrases
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • multiple myeloma
  • hodgkin lymphoma
  • diffuse large b cell lymphoma
  • open label
  • double blind
  • placebo controlled
  • clinical trial
  • randomized controlled trial